R Michael Carruthers, Chief Financial Officer at Fresh Tracks Therapeutics, holds ― shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds 29.02K shares in Edgewise Therapeutics (Ticker: EWTX), holds ― shares in Elevation Oncology (Ticker: ELEV). Most recently, R Michael Carruthers ― shares of Fresh Tracks Therapeutics on ― for an estimated value of ―.